Department of Human Population Genetics, Institute of Molecular Medicine, Peking University, Beijing, China.
Department of Cardiolody, Affiliated Hospital of Jining Medical University, Jining, China.
PLoS One. 2013 Dec 11;8(12):e82135. doi: 10.1371/journal.pone.0082135. eCollection 2013.
Coronary artery disease (CAD) is the leading cause of death and disability in the world. Genome-wide association studies have implicated the importance of the genetic contribution of vascular smooth muscle cells (VSMCs) function in CAD susceptibility. The aberrant phenotypic modulation of VSMC is responsible for the pathological vascular intima hyperplasia that is the hallmark for atherosclerotic morphology. NEXN is a muscle-specific F-actin binding protein and is regulated by inflammatory cytokines in VSMCs. Whether NEXN contributes to human vascular disorders is still unknown. In this study, we genotyped 5 SNPs, tagging all of the 17 common SNPs within 54 kilobases (kb) covering NEXN gene and its flanking region, in 1883 patients with CAD and 1973 healthy individuals from Han Chinese, and identified one SNP, rs1780050, which was strongly associated with CAD trait. The Bonferroni corrected P-value was 7.65×10(-5). The odds ratio (95% confidence interval) was 1.23 (1.12-1.36) with statistical power of 0.994. Functional analysis showed that NEXN promotes VSMC to a contractile phenotype in vitro and inhibits balloon-injury induced neointima formation in vivo. Further eQTL analysis demonstrated that the risk allele T of rs1780050 is associated with decreased expression of NEXN, thus contributing to a higher risk of CAD susceptibility in the population. This is, to our knowledge, the first study to identify NEXN as a novel CAD susceptibility gene with both genetic and functional evidence.
冠状动脉疾病(CAD)是世界上导致死亡和残疾的主要原因。全基因组关联研究表明,血管平滑肌细胞(VSMCs)功能的遗传贡献对 CAD 易感性具有重要意义。VSMC 表型异常调节导致病理性血管内膜增生,这是动脉粥样硬化形态的标志。NEXN 是一种肌特异性 F-肌动蛋白结合蛋白,在 VSMCs 中受炎症细胞因子调节。NEXN 是否导致人类血管疾病尚不清楚。在这项研究中,我们对 1883 名 CAD 患者和 1973 名汉族健康个体中的 54 千碱基(kb)覆盖 NEXN 基因及其侧翼区域的 5 个 SNP 进行了基因分型,这些 SNP 标记了 NEXN 基因中的所有 17 个常见 SNP,并确定了一个 SNP,rs1780050,与 CAD 表型强烈相关。Bonferroni 校正后的 P 值为 7.65×10(-5)。优势比(95%置信区间)为 1.23(1.12-1.36),统计效力为 0.994。功能分析表明,NEXN 在体外促进 VSMC 向收缩表型转化,并抑制体内球囊损伤诱导的新生内膜形成。进一步的 eQTL 分析表明,rs1780050 的风险等位基因 T 与 NEXN 表达降低相关,从而导致人群中 CAD 易感性的风险增加。这是首次在遗传和功能证据方面将 NEXN 鉴定为一种新的 CAD 易感基因。